Serum amyloid P component bound to gram-negative bacteria prevents lipopolysaccharide-mediated classical pathway complement activation

Infection and Immunity

Volumn 68, Issue 4, 2000, Pages 1753-1759

  De Haas, Carla J C ^a   Van Leeuwen, Ester M M ^a   Van Bommel, Toon ^a   Verhoef, Jan ^a   Van Kessel, Kok P M ^a   Van Strijp, Jos A G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID P COMPONENT; BACTERIUM LIPOPOLYSACCHARIDE;

ARTICLE; COMPLEMENT ACTIVATION; CYTOLYSIS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SALMONELLA ENTERICA;

ANIMALS; ANTIBODIES, MONOCLONAL; COMPLEMENT ACTIVATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; GRAM-NEGATIVE BACTERIA; HUMANS; HYBRIDOMAS; LIPOPOLYSACCHARIDES; MICE; NEUTROPHILS; PHAGOCYTOSIS; SALMONELLA TYPHIMURIUM; SERUM AMYLOID P-COMPONENT;

EID: 0034106274     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.4.1753-1759.2000     Document Type: Article

References (30)

1. Betz, S. J., and H. Isliker. 1981. Antibody-independent interactions between Escherichia coli J5 and human complement components. J. Immunol. 127: 1748-1754.
2. Betz, S. J., N. Page, C. Estrade, and H. Isliker. 1982. The effect of specific antibody on antibody-independent interactions between E. coli J5 and human complement. J. Immunol. 128:707-711.
3. Bone, R. C. 1991. The pathogenesis of sepsis. Ann. Intern. Med. 115:457-469.
4. Bristow, C. L., and R. J. Boackle. 1986. Evidence for the binding of human serum amyloid P component to Clq and Fab. Mol. Immunol. 23:1045-1052.
5. Brown, M. R., and B. E. Anderson. 1993. Receptor-ligand interactions between serum amyloid P component and model soluble immune complexes. J. Immunol. 151:2087-2095.
6. Catana, E., and J. A. Schifferli. 1991. Purification of human complement factor D from the peritoneal fluid of patients on chronic ambulatory peritoneal dialysis. J. Immunol. Methods 138:265-271.
7. de Haas, C. J. C., P.-J. Haas, K. P. M. van Kessel, and J. A. G. van Strijp. 1998. Affinities of different proteins and peptides for lipopolysaccharide (LPS) as determined by biosensor technology. Biochem. Biophys. Res. Commun. 252:492-496.
8. de Haas, C. J. C., M. E. van der Tol, K. P. M. van Kessel, J. Verhoef, and J. A. G. van Strijp. 1998. A synthetic lipopolysaccharide (LPS)-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits LPS-induced responses in human blood. J. Immunol. 161:3607-3615.
9. Emsley, J., H. E. White, B. P. O'Hara, G. Oliva, N. Srinivasan, I. J. Tickle, T. L. Blundell, M. B. Pepys, and S. P. Wood. 1994. Structure of pentameric human serum amyloid P component. Nature 367:338-345.
10. Garcia de Frutos, P., and B. Dahlback. 1994. Interaction between serum amyloid P component and C4b-binding protein associated with inhibition of factor I-mediated C4b degradation. J. Immunol. 152:2430-2437.
11. Garcia de Frutos, P., Y. Hardig, and B. Dahlback. 1995. Serum amyloid P component binding to C4b-binding protein. J. Biol. Chem. 270:26950-26955.
12. Hammer, C. H., G. H. Wirtz, L. Renfer, H. D. Gresham, and B. F. Tack. 1981. Large scale isolation of functionally active components of the human complement system. J. Biol. Chem. 256:3995-4006.
13. +. Description of a novel deep-rough chemotype. Eur. J. Biochem. 177:483-492.
14. Hicks, P. S., L. Saunero Nava, T. W. Du Clos, and C. Mold. 1992. Serum amyloid P component binds to histones and activates the classical complement pathway. J. Immunol. 149:3689-3694.
15. Hind, C. R., P. M. Collins, M. L. Baltz, and M. B. Pepys. 1985. Human serum amyloid P component, a circulating lectin with specificity for the cyclic 4,6-pyruvate acetal of galactose. Interactions with various bacteria. Biochem. J. 225:107-111.
16. Horwitz, M. A. 1980. The roles of the Fc and C3 receptors in the phagocytosis and killing of bacteria by human phagocytes. J. Reticuloendothel. Soc. 28(Suppl.):17s-26s.
17. Kalaria, R. N., P. G. Galloway, and G. Perry. 1991. Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders. Neuropathol. Appl. Neurobiol. 17:189-201.
18. Klerx, J. P. A. M., C. J. Beukelman, H. Van Dijk, and J. M. N. Willers. 1983. Microassay for colorimetric estimation of complement activity in guinea pig, human and mouse serum. J. Immunol. Methods 63:215-220.
19. Landsmann, P., O. Rosen, M. Pontet, M. Pras, D. Levartowsky, E. G. Shephard, and M. Fridkin. 1994. Binding of human serum amyloid P component (hSAP) to human neutrophils. Eur. J. Biochem. 223:805-811.
20. Leijh, P. C. J., M. T. van den Barselaar, T. L. van Zwet, M. R. Daha, and R. van Furth. 1979. Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes. J. Clin. Investig. 63:772-784.
21. Pepys, M. B., A. C. Dash, R. E. Markham, H. C. Thomas, B. D. Williams, and A. Petrie. 1978. Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum. Clin. Exp. Immunol. 32:119-124.
22. Preston, A., R. E. Mandrell, B. W. Gibson, and M. A. Apicella. 1996. The lipooligosaccharides of pathogenic gram-negative bacteria. Crit. Rev. Microbiol. 22:139-180.
23. Raetz, C. R. H. 1990. Biochemistry of endotoxins. Annu. Rev. Biochem. 59:129-170.
24. Schwalbe, R. A., B. Dahlback, and G. L. Nelsestuen. 1990. Independent association of serum amyloid P component, protein S, and complement C4b with complement C4b-binding protein and subsequent association of the complex with membranes. J. Biol. Chem. 265:21749-21757.
25. Sorensen, I. J., E. H. Nielsen, O. Andersen, B. Danielsen, and S. E. Svehag. 1996. Binding of complement proteins Clq and C4bp to serum amyloid P component (SAP) in solid contra liquid phase. Scand. J. Immunol. 44:401-407.
26. Troelstra, A., B. N. G. Giepmans, K. P. M. van Kessel, H. S. Lichenstein, J. Verhoef, and J. A. G. van Strijp. 1997. Dual effects of soluble CD14 on LPS priming of neutrophils. J. Leukoc. Biol. 61:173-178.
27. Veldkamp, K. E., K. P. M. van Kessel, J. Verhoef, and J. A. G. van Strijp. 1997. Staphylococcal culture supernates stimulate human phagocytes. Inflammation 21:541-551.
28. Vreede, R. W., J. H. Marcelis, and J. Verhoef. 1986. Antibodies raised against rough mutants of Escherichia coli and Salmonella strains are opsonic only in the presence of complement. Infect. Immun. 52:892-896.
29. Wright, S. D., L. S. Craigmyle, and S. C. Silverstein. 1983. Fibronectin and serum amyloid P component stimulate C3b- and C3bi-mediated phagocytosis in cultured human monocytes. J. Exp. Med. 158:1338-1343.
30. Ying, S. C., A. T. Gewurz, H. Jiang, and H. Gewurz. 1993. Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of Clq. J. Immunol. 150:169-176.